MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT
about
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic DiseasesDipeptidyl peptidase-4 and kidney fibrosis in diabetesEpithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?The Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound HealingIntratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasisN-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetesNon-coding RNAs and gastric cancerThe role of uric acid in kidney fibrosis: experimental evidences for the causal relationship.Effect of benazepril on the transdifferentiation of renal tubular epithelial cells from diabetic rats.Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer.Coding and noncoding expression patterns associated with rare obesity-related disorders: Prader-Willi and Alström syndromes.MicroRNA-215 Regulates Fibroblast Function: Insights from a Human Fibrotic Disease.Low molecular weight fucoidan ameliorates diabetic nephropathy via inhibiting epithelial-mesenchymal transition and fibrotic processes.MiR-630 Inhibits Endothelial-Mesenchymal Transition by Targeting Slug in Traumatic Heterotopic Ossification.miR-34c attenuates epithelial-mesenchymal transition and kidney fibrosis with ureteral obstruction.Epigenetics in radiation-induced fibrosis.The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis.Lipid mediators in diabetic nephropathy.FGFR1 is critical for the anti-endothelial mesenchymal transition effect of N-acetyl-seryl-aspartyl-lysyl-proline via induction of the MAP4K4 pathway.Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition.The role of microRNAs in gallbladder cancer.Noncoding RNA and epigenetic gene regulation in renal diseases.The mechanism of TGF-β/miR-155/c-Ski regulates endothelial-mesenchymal transition in human coronary artery endothelial cells.Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney FibrosisSrc Homology 2 Domain-Containing Inositol 5'-Phosphatase Ameliorates High Glucose-Induced Extracellular Matrix Deposition via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Renal Tubular Epithelial Cells.Human Fibrotic Diseases: Current Challenges in Fibrosis Research.The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin.PTEN Regulates Renal Extracellular Matrix Deposit via Increased CTGF in Diabetes Mellitus.SIRT3 deficiency leads to induction of abnormal glycolysis in diabetic kidney with fibrosis
P2860
Q26748338-B96B558B-31CD-4E49-B2BA-05260316C7ECQ26766089-EE077F43-F24F-442F-834A-2682DDC54A32Q26782283-93FD925D-A341-4F0F-B3AF-5878061EB3AEQ26827627-C3EACFB5-9693-46CE-A712-B9C9790EE5EEQ26991480-B2EF9EB3-9664-4E5B-BC7D-48CBE0CAC5C5Q27008887-DE6AA8A4-FD63-42F5-AF0B-94EFE235ADB1Q33594919-575FEC18-C506-42E3-938B-81EECE5A2780Q33634704-0695E63B-C72B-4846-A2F3-1964EB008820Q33733552-FD2BF206-0730-4798-91C1-A1DC63406EBCQ34177065-8FA70D24-1A75-430A-AD0B-286E3AE77E13Q35100466-D704A780-8439-4545-B7B0-6A0D5F6BDEF1Q36183742-C931E031-353E-4CF1-B9A2-3096F58430A4Q36225834-975CEFBF-3120-461F-9571-0C4998E6DC65Q36651240-A3823D88-4477-45C3-B907-5BC30E43C528Q37681848-1267C7DE-15D8-4899-A2DE-CF675B4481A4Q38218535-B72BC9E2-DD1D-4CD9-926A-26997DC547A0Q38224257-4655F592-2D2B-495B-9B0F-90E44820D7A0Q38248011-D0E3E260-554B-4C3C-AB09-5172A64A38F4Q38644648-768CDA52-611C-4400-86BD-F199AC33EED7Q38725402-5D322079-C9AE-435D-ABA0-971B1C74AB67Q38872859-4C48132B-5D88-4CF8-A8DF-05D748D2ADD4Q39294086-EEF90632-E603-4937-8C69-21DF48F4EF1CQ41504730-D8348F5F-5E7F-4B1A-9343-ABC2322EFEFEQ41832445-95DFCE50-7039-4D85-8336-6294A63971E0Q51200743-522E6584-A7FD-4C4F-A934-EA7DCCD86041Q52536468-D2820976-0F1B-4903-A72D-C45D65709EACQ52688968-64AA643D-8989-4BAF-B83A-F700AAC8DE91Q54241717-94DC3E54-BE5F-41EF-99D8-483F89A80E35Q58700312-4D2B5CA7-F235-44B1-AC25-C267B8BA89F8
P2860
MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT
@ast
MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT
@en
MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT
@nl
type
label
MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT
@ast
MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT
@en
MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT
@nl
prefLabel
MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT
@ast
MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT
@en
MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT
@nl
P2093
P2860
P3181
P356
P1476
MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT
@en
P2093
Daisuke Koya
Keizo Kanasaki
Swayam Prakash Srivastava
P2860
P304
P3181
P356
10.1155/2013/125469
P407
P577
2013-01-01T00:00:00Z
2013-09-08T00:00:00Z